6 results match your criteria: "Nagoya University Graduate School of MedicineNagoya[Affiliation]"

Article Synopsis
  • Advanced melanoma treatment has shifted from low-survival chemotherapy options like DTIC to more effective immunotherapies and targeted therapies, although high costs remain an issue.
  • This study explored the combined effect of HF10, a modified virus, with DTIC in mice to improve treatment outcomes, observing significant tumor growth inhibition and increased survivability compared to monotherapy.
  • Results indicated that the combination therapy not only showed enhanced cytotoxicity and tumor clearance but also stimulated a strong systemic immune response, evidenced by increased IFN-γ secretion from immune cells.
View Article and Find Full Text PDF

The Associations among Insulin Resistance, Hyperglycemia, Physical Performance, Diabetes Mellitus, and Cognitive Function in Relatively Healthy Older Adults with Subtle Cognitive Dysfunction.

Front Aging Neurosci

March 2017

Department of Community Healthcare and Geriatrics, Nagoya University Graduate School of MedicineNagoya, Japan; Institute of Innovation for Future Society, Nagoya UniversityNagoya, Japan.

Insulin resistance (IR), diabetes mellitus (DM), sarcopenia, and cognitive dysfunction are thought to be mutually associated. We conducted a comprehensive assessment of the relationships among IR, gait speed, hyperglycemia, and DM by cross-sectionally analyzing the baseline data of an interventional study for cognitive preservation with physical exercise (the TOyota Preventional Intervention for Cognitive decline and Sarcopenia [TOPICS]). The participants ( = 444) were relatively healthy older individuals who had mild cognitive impairment without dementia, and 61 of the participants had DM.

View Article and Find Full Text PDF

General electric devices and ventilation systems are known to generate low frequency noise (LFN) with frequencies of <100 Hz. Previous studies showed that exposure to LFN caused impairments of balance in humans and mice during adulthood. On the other hand, a previous study showed that noise levels in the neonatal intensive care unit (NICU) were greater than those in general home or office environments.

View Article and Find Full Text PDF

APOBEC3G-Mediated G-to-A Hypermutation of the HIV-1 Genome: The Missing Link in Antiviral Molecular Mechanisms.

Front Microbiol

December 2016

Department of Microbiology and Immunology, Laboratory of Infectious Diseases, Clinical Research Center, National Hospital Organization Nagoya Medical CenterNagoya, Japan; Department of AIDS Research, Nagoya University Graduate School of MedicineNagoya, Japan.

APOBEC3G (A3G) is a member of the cellular polynucleotide cytidine deaminases, which catalyze the deamination of cytosine (dC) to uracil (dU) in single-stranded DNA. These enzymes potently inhibit the replication of a variety of retroviruses and retrotransposons, including HIV-1. A3G is incorporated into -deficient HIV-1 virions and targets viral reverse transcripts, particularly minus-stranded DNA products, in newly infected cells.

View Article and Find Full Text PDF

The recurrent network composed of excitatory and inhibitory neurons is fundamental to neocortical function. Inhibitory neurons in the mammalian neocortex are molecularly diverse, and individual cell types play unique functional roles in the neocortical microcircuit. Recently, vasoactive intestinal polypeptide-positive (VIP+) neurons, comprising a subclass of inhibitory neurons, have attracted particular attention because they can disinhibit pyramidal cells through inhibition of other types of inhibitory neurons, such as parvalbumin- (PV+) and somatostatin-positive (SOM+) inhibitory neurons, promoting sensory information processing.

View Article and Find Full Text PDF

Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance.

Front Microbiol

February 2016

Department of Infectious Diseases and Immunology, Clinical Research Center, National Hospital Organization Nagoya Medical CenterNagoya, Japan; Department of AIDS Research, Nagoya University Graduate School of MedicineNagoya, Japan.

Darunavir (DRV) is one of the most powerful protease inhibitors (PIs) for treating human immunodeficiency virus type-1 (HIV-1) infection and presents a high genetic barrier to the generation of resistant viruses. However, DRV-resistant HIV-1 infrequently emerges from viruses exhibiting resistance to other protease inhibitors. To address this resistance, researchers have gathered genetic information on DRV resistance.

View Article and Find Full Text PDF